Social Links

Follow on Facebook Follow on Twitter Follow on G+Follow EiR on PinterestFollow EiR on Instagram

Xpert Access

×

Login To Get Involved!


Forgot your username?


Forgot your password?

DNRS Roof Banner

 

DNRS Interactive DVD Series & Seminars

The Vomeronasal Organ and CS - References

 

 

 

 

1. Fiedler N, Kipen H. Chemical sensitivity: the scientific literature. Environ Health Perspect 105(suppl 2):409-415 (1997).

 

2. Graveling RA, Pilkington A, Georg JPK, Bulter MP, Tannahill SN. A review of multiple chemical sensitivity. Occup Environ Med 56:73-85 (1999).

 

3. Ross PM, Whysner J, Covello VT, Kuschner M, Rifkind AB, Sedler MJ, Trichopoulos D, Williams GM. Olfaction and symptoms in the multiple chemical sensitivities syndrome. Prev Med 28:467-480 (1999).

 

4. Nethercott JR, Davidoff LL, Curbow B, Abbey H. Multiple chemical sensitivities: toward a working case definition. Arch Environ Health 48:19-26 (1993).

 

5. Kipen HM, Hallman W, Kang H, Fiedler N, Natelson BH. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry veterans. Arch Environ Health 54:313-318 (1999).

 

6. Kaires P. Symptoms in Persian Gulf War veterans. J Occup Environ Med 41:939 (1999).

 

7. Miller CS, Pridhoda TJ. A controlled comparison of symptoms and chemical intolerances reported by Gulf War veterans, implant recipients and persons with multiple chemical sensitivity. Toxicol Ind Health 15:386-397 (1999).

 

8. Weiss B. Neurobehavioral properties of chemical sensitivity syndromes. Neurotoxicology 19:259-268 (1998).

 

9. Kipen H, Fiedler N. Introduction and overview. Environ Health Perspect 105(suppl 2):405-407 (1997).

 

10. Shusterman D. Critical review: the health significance of environmental odor pollution. Arch Environ Health 47:76-87 (1992).

 

11. Gots RE. Medical hypothesis and medical practice: autointoxication and multiple chemical sensitivities. Regul Toxicol Pharmacol 18:2-12 (1993).

 

12. MacPhail RC. Evolving concepts of chemical sensitivity. Environ Health Perspect 105:455-456 (1997).

 

13. Black DW, Rathe A, Goldstein RB. Environmental illness: a controlled study of 26 subjects with "20th century disease." JAMA 264:3166-3170 (1990).

 

14. Brown AE. Developing a pesticide policy for individuals with multiple chemical sensitivity: considerations for institutions. Toxicol Ind Health 15:432-437 (1999).

 

15. Dyer RS, Sexton K. What can research contribute to regulatory decisions about the health risks of multiple chemical sensitivity? Regul Toxicol Pharmacol 24:S139-S151 (1996).

 

16. Ashford NA. Low-level chemical sensitivity: implications for research and social policy. Toxicol Ind Health 15:421-427 (1999).

 

17. Lax MB. Multiple chemical sensitivities: the social construction of an illness. Int J Health Services 28:725-745 (1998).

 

18. Custer WV, Kertschner ET. The development of judicial policy on the phenomenon of multiple chemical sensitivity in the post-Daubert era. Toxicol Ind Health 15:428-431 (1999).

 

19. Sparks PJ, Daniell W, Black DW, Kipen HM, Altman LC, Simon GE, Terr AI. Multiple chemical sensitivity syndrome: a clinical perspective. I: Case definition, theories of pathogenesis, and research needs. J Occup Med 36:718-730 (1994).

 

20. Bell IR, Schwartz GE, Peterson JM, Amend D. Self-reported illness from chemical odors in young adults without clinical syndromes or occupational exposures. Arch Environ Health 48:6-13 (1993).

 

21. Bartha L, Baumzweiger W, Buscher DS, Callender T, Dahl KA, Davidoff A, Donnay A, Edelson SB, Elson BD, Elliott E, et al. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health 54:147-149 (1999).

 

22. Fiedler N, Maccia C, Kipen H. Evaluation of chemically sensitive patients. J Occup Med 34:529-538 (1992).

 

23. Sparks PJ, Daniell W, Black DW, Kipen HW, Altman LC, Simon GE, Terr AI. Multiple chemical sensitivity syndrome: a clinical perspective. II: Evaluation, diagnostic testing, treatment, and social considerations. J Occup Med 36:731-737 (1994).

 

24. Kipen HM, Fiedler N. Invited commentary: sensitivities to chemicals--context and implications. Am J Epidemiol 150:13-16 (1999).

 

25. Kipen HM, Hallman W, Kelly-McNeill K, Fiedler N. Measuring chemical sensitivity prevalence: a questionnaire for population studies. Am J Pub Health 85:574-577 (1995).

 

26. Cullen MR. The worker with chemical sensitivity: an overview. In: Workers with Multiple Chemical Sensitivities. Occupational Medicine: State of the Art Reviews, Vol 2 (Cullen MR, ed). Philadelphia:Hanley & Belfus, 1987; 655-662.

 

27. Baldwin CM, Bell IR, O'Rourke MK. Odor sensitivity and respiratory complaint profiles in a community-based sample with asthma, hay fever, and chemical odor intolerance. Toxicol Ind Health 15:403-409 (1999).

 

28. Dreger M, ed. ACOEM Updates Position on Multiple Chemical Sensitivities. ACOEM Report June 1999. Arlington Heights, IL:American College of Occupational and Environmental Medicine, 1999;1-3.

 

29. Amundsen MA, Hanson NP, Bruce BK, Lantz TD, Schwartz MS, Lukach BM. Odor aversion or multiple chemical sensitivities: recommendation for a name change and description of successful behavioral medicine treatment. Regul Toxicol Pharmacol 24:S116-S118 (1996).

 

30. Szarek MJ, Bell IR, Schwartz GE. Validation of a brief screening measure of environmental chemical sensitivity: the chemical odor intolerance index. J Environ Psychol 17:345-351 (1997).

 

31. Bowler RM, Huel G, Mergler D, Cone JE, Rauch SS, Hartney C. Symptom base rates after chemical exposure for White, Hispanic, and African-Americans. Neurotoxicology 17:793-802 (1996).

 

32. Hirzy J, Morrison R. Carpet/4-phenylcyclohexene toxicity: the EPA headquarters case. Presented at the Annual Meeting of the Society for Risk Analysis, 29 October-1 November 1989, San Francisco, California, 1989.

 

33. White MC, Johnson CA, Ashley DL, Buchta TM, Pelletier DJ. Exposure to methyl tertiary-butyl ether from oxygenated gasoline in Stamford, Connecticut. Arch Environ Health 50:183-189 (1995).

 

34. Cone J, Sult T. Acquired intolerance to solvents following pesticide exposure in a building. Toxicol Ind Health 8:29-39 (1992).

 

35. Miller CS. Are we on the threshold of a new theory of disease? Toxicant-induced loss of tolerance and its relationship to addiction and abdiction. Toxicol Ind Health 15:284-294 (1999).

 

36. Fiedler N, Kipen HM, DeLuca J, Kelly-McNeill K, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med 58:38-49 (1996).

 

37. Meggs WJ, Dunn KA, Bloch RM, Goodman PE, Davidoff AL. Prevalence and nature of allergy and chemical sensitivity in a general population. Arch Environ Health 51:275-282 (1996).

 

38. Kreutzer R, Neutra RR, Lashuay N. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am J Epidemiol 150:1-12 (1999).

 

39. Kipen HM, Fiedler N, Lehrer P. Multiple chemical sensitivities: a primer for pulmonologists. Clin Pulm Med 4:76-84 (1997).

 

40. Bell I, Miller C, Schwartz G. An olfactory-limbic model of multiple chemical sensitivity syndrome: possible relationships to kindling and affective spectrum disorders. Biol Psychiatry 32:218-242 (1992).

 

41. Meggs WJ. Mechanisms of allergy and chemical sensitivity. Toxicol Ind Health 15:331-338 (1999).

42. Meggs WJ, Cleveland CH. Rhinolaryngoscopic examination of patients with multiple chemical sensitivity syndrome. Arch Environ Health 48:14-18 (1993).

 

43. Bascom R. Multiple chemical sensitivity: a respiratory disorder? Toxicol Ind Health 8:221-228 (1992).

 

44. Miller CS. Toxicant-induced loss of tolerance--an emerging theory of disease? Environ Health Perspect 105:445-453 (1997).

 

45. Siegel S, Kreutzer R. Pavlovian conditioning and multiple chemical sensitivity. Environ Health Perspect 105(suppl 2):521-526 (1997).

 

46. Siegel S. Multiple chemical sensitivity as a conditional response. Toxicol Ind Health 15:323-330 (1999).

 

47. Bolla-Wilson K, Wilson R, Bleecker ML. Conditioning of physical symptoms after neurotoxic exposures. J Occup Med 30:684-686 (1988).

 

48. Van den Bergh O, Stegen K, Van Diest I, Raes C, Stulens P, Eelen P, Veulemans H, Van de Woestijne KP, Nemery B. Acquisition and extinction of somatic symptoms in response to odours: a Pavlovian paradigm relevant to multiple chemical sensitivity. Occup Environ Med 56:295-301 (1999).

 

49. Simon GE, Daniell W, Stockbridge H, Claypoole K, Rosenstock L. Immunological, psychological, and neuropsychological factors in multiple chemical sensitivity: a controlled study. Ann Intern Med 19:97-103 (1993).

 

50. Shusterman DJ, Dager SR. Prevention of psychological disability after occupational respiratory exposures. In: Prevention of Pulmonary Disease. Occupational Medicine: State of the Art Reviews, Vol 6 (Harber P, Balmes JR, eds). Philadelphia:Hanley & Belfus, 1987;11-27.

 

51. Wysocki, CJ. Neurobehavioral evidence for the involvement of the vomeronasal system in mammalian reproduction. Neurosci Behav Rev 3:301-341 (1979).

 

52. McClintock M. Menstrual synchrony and suppression. Nature 229:244-245 (1971).

 

53. Karlson P, Luscher M. Pheromones: a new term for a class of biologically active substances. Nature 183:55-56 (1959).

 

54. Matsunami H, Buck LB. A multigene family encoding a diverse array of putative pheromone receptors in mammals. Cell 90:775-784 (1997).

 

55. Ruysch F. Thesaurus Anatomicus, Vol 3. Amsterdam:Wolters, 1703.

 

56. Jacobson L. Description anatomique d'un organe observe dans les mammiferes. Ann Mus Hist Nat Paris 18:412-424 (1811).

 

57. Potiquet M. Le canal de Jacobson. Rev Laryngol (Paris) 2:737-753 (1891).

 

58. Johnson A, Josephson R, Hawke M. Clinical and histological evidence for the presence of the vomeronasal (Jacobson's) organ in adult humans. J Otolaryngol 14:71-79 (1985).

 

59. Monti-Bloch L, Jennings-White C, Berliner DL. The human vomeronasal system. A review. Ann NY Acad Sci 855:373-389 (1998).

 

60. Monti-Bloch L, Jennings-White C, Dolberg DS, Berliner DL. The human vomeronasal system. Psychoneuroendocrinology 19:673-686 (1994).

 

61. Keverne EB. The vomeronasal organ. Science 286:716-720 (1999).

 

62. Moran DT, Jafek BW, Rowley JC. The vomeronasal (Jacobson's) organ in man: ultrastructure and frequency of occurrence. J Steroid Biochem Molec Biol 39:545-552 (1991).

 

63. Trotier D, Eloit C, Wassef M, Talmain G, Bensimon JL, Doving KB, Ferrand J. The vomeronasal cavity in adult humans. Chem Senses 25:369-380 (2000).

 

64. Abolmaali ND, Kuhnau D, Knecht M, Kohler K, Huttenbrink KB, Hummel T. Imaging of the human vomeronasal duct. Chem Senses 26:35-39 (2001).

 

65. Stensaas LJ, Lavker RM, Monti-Bloch L, Grosser BI, Berliner DL. Ultrastructure of the human vomeronasal organ. J Steroid Biochem Mol Biol 39:553-560 (1991).

 

66. Monti-Bloch L. Effect of vomeropherin pregna-4,20-diene-3,6-dione on isolated cells from the human vomeronasal organ. Chem Senses 22:752 (1997).

 

67. Takami S, Getchell ML, Chen Y, Monti-Bloch L, Berliner DL, Stensaas LJ, Getchell TV. Vomeronasal epithelial cells of the adult human express neuron-specific molecules. NeuroReport 4:375-378 (1993).

 

68. Barber PC, Raisman G. An autoradiographic investigation of the projection of the vomeronasal organ to the accessory olfactory bulb in the mouse. Brain 81:21-30 (1974).

 

69. Garcia-Velasco J, Mondragon M. The incidence of the vomeronasal organ in 1000 human subjects and its possible clinical significance. J Steroid Biochem Molec Biol 39:561-563 (1991).

 

70. Moran DT, Monti-Bloch L, Stensaas LJ, Berliner DL. Structure and function of the human vomeronasal organ. In: Handbook of Olfaction and Gustation (Doty RL, ed). New York:Marcel Dekker, 1995;793-820.

 

71. Zbar RIS, Zbar LIS, Dudley C, Trott SA, Rohrich RJ, Moss RL. A classification schema for the vomeronasal organ in humans. Plast Reconstr Surg 105:1284-1288 (2000).

 

72. Jacob S, Zelano B, Gungor A, Abbott D, Naclerio R, McClintock MK. Location and gross morphology of the nasopalatine duct in human adults. Arch Otolaryngol Head Neck Surg 126:741-748 (2000).

 

73. Monti-Bloch L, Jennings-White C, Dolberg DS, Berliner DL. The human vomeronasal system. Psychoneuroendocrinology 19:673-686 (1994).

 

74. Monti-Bloch L, Grosser BI. Effect of putative pheromones on the electrical activity of the human vomeronasal organ and olfactory epithelium. J Steroid Biochem Mol Biol 39:573-582 (1991).

 

75. Monti-Bloch L. Combined Neuroepithelial Sample Delivery Electrode Device and Methods of Using Same. U.S. Patent No. 5,303,703 (April 1994).

 

76. Osterhammel P, Terkildsen K, Zilstorff K. Electro-olfactograms in man. J Laryngol 83:731-733 (1969).

 

77. Berliner DL, Monti-Bloch L, Jennings-White C, Diaz-Sanchez V. The functionality of the human vomeronasal organ (VNO): evidence for steroid receptors. J Steroid Biochem Mol Biol 58:259-265 (1996).

 

78. Berliner DL. Steroidal substances active in the human vomeronasal organ affect hypothalamic function. J Steroid Biochem Molec Biol 58:1-2 (1996).

 

79. Stern K, McClintock MK. Regulation of ovulation by human pheromones. Nature 392:177-179 (1998).

 

80. Cutler WB, Preti G, Krieger A, Huggins GR, Garcia CR. Layley HJ. Human axillary secretions influence women's menstrual cycles: the role of donor extract from men. Horm Behav 20:463-473 (1986).

 

81. Preti G, Cutler WB, Garcia CR, Huggins GR, Lawley HJ. Human axillary secretions influence women's menstrual cycles: the role of donor extract of females. Horm Behav 20:474-482 (1986).

 

82. Sobel N, Prabhakaran V, Hartley CA, Desmond JE, Glover GH, Sullivan, EV, Gabrieli JDE. Blind smell: brain activation induced by an undetected air-borne chemical. Brain 122:209-217 (1999).

 

83. Grosser BI, Monti-Bloch L, Jennings-White C, Berliner DL. Behavioral and electrophysiological effects of androstadienone, a human pheromone. Psychoneuroendocrinology 25:289-299 (2000).

 

84. Monti-Bloch L, Diaz-Sanchez V, Jennings-White C, Berliner DL. Modulation of serum testosterone and autonomic function through stimulation of the male human vomeronasal organ (VNO) with pregna-4,20-diene-3,6-dione. J Steroid Biochem Mol Biol 65:237-242 (1998).

 

85. Kastin AJ, Banks W, Ahmed B, Zadina JE. Influence of hormones and messenger peptides on normal brain function. In: Principles and Practice of Endocrinology and Metabolism (Becker KL, ed). Philadelphia:JB Lippincott, 1995;1682-1691.

 

86. Leigh H. Cerebral effects of endocrine disease. In: Principles and Practice of Endocrinology and Metabolism (Becker KL, ed). Philadelphia:JB Lippincott, 1995;1691-1695.

 

87. Rohatgi PK, Becker KL. Respiration and endocrinology. In: Principles and Practice of Endocrinology and Metabolism (Becker KL, ed). Philadelphia:JB Lippincott, 1995;1703-1713.

 

88. Layzer RB. Neuromuscular manifestations of endocrine disease. In: Principles and Practice of Endocrinology and Metabolism (Becker KL, ed). Philadelphia:JB Lippincott, 1995;1762-1770.

 

89. Halline AG, Glaws WR, Kraft SC. Gastrointestinal manifestations of endocrine disease. In: Principles and Practice of Endocrinology and Metabolism (Becker KL, ed). Philadelphia:JB Lippincott, 1995;1721-1725.

 

90. Greene GJ. Nasal responses to airborne environmental chemicals. Grant no. K23 ES00385. Bethesda, MD:National Institute of Environmental Health Sciences, National Institutes of Health.

 


 

 

Related Articles: